1 |
VUJOSEVIC S, ALDINGTON S J, SILVA P, et al. Screening for diabetic retinopathy: new perspectives and challenges[J]. Lancet Diabetes Endocrinol, 2020,8(4): 337-347.
|
2 |
RAJKUMAR K V, LAKSHMANAN G, SEKAR D. Identification of miR-802-5p and its involvement in type 2 diabetes mellitus[J]. World J Diabetes, 2020, 11(12): 567-571.
|
3 |
WANG J L, WU G Y, CHU H P, et al. Paeonol derivatives and pharmacological activities: a review of recent progress[J]. Mini Rev Med Chem, 2020, 20(6): 466-482.
|
4 |
ZHANG L, CHEN Z Q, GONG W Y, et al. Paeonol ameliorates diabetic renal fibrosis through promoting the activation of the Nrf2/ARE pathway via up-regulating Sirt1[J]. Front Pharmacol, 2018, 9: 512.
|
5 |
MEI L Y, HE M H, ZHANG C Y, et al. Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p[J]. Sci Rep,2019,9(1):19370.
|
6 |
MARTINEZ B, PEPLOW P V. MicroRNAs as biomarkers of diabetic retinopathy and disease progression[J].Neural Regen Res, 2019, 14(11): 1858-1869.
|
7 |
PLATANIA C B M, MAISTO R, TROTTA M C,et al.Retinal and circulating miRNA expression patterns in diabetic retinopathy: an in silico and in vivo approach[J].Br J Pharmacol,2019,176(13):2179-2194.
|
8 |
ZHAO J Y, GAO S, ZHU Y J, et al. Significant role of microRNA‑219‑5p in diabetic retinopathy and its mechanism of action[J]. Mol Med Rep, 2018, 18(1): 385-390.
|
9 |
GU C F, DRAGA D, ZHOU C D, et al. miR-590-3p inhibits pyroptosis in diabetic retinopathy by targeting NLRP1 and inactivating the NOX4 signaling pathway[J]. Invest Ophthalmol Vis Sci, 2019,60(13): 4215-4223.
|
10 |
CALADO S M, DIAZ-CORRALES F, SILVA G A. pEPito-driven PEDF expression ameliorates diabetic retinopathy hallmarks[J]. Hum Gene Ther Methods, 2016, 27(2): 79-86.
|
11 |
MANSOUR S E, BROWNING D J, WONG K, et al. The evolving treatment of diabetic retinopathy[J]. Clin Ophthalmol, 2020, 14: 653-678.
|
12 |
杨 洁, 冉 明, 郜会龙. miR-429在糖尿病视网膜病变中的表达和对AKT信号通路的影响[J]. 眼科新进展, 2020, 40(10): 929-932.
|
13 |
ZHENG Y R, LIU Y, WANG L L, et al. MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4[J]. Int J Mol Med, 2021, 47(1): 151-160.
|
14 |
KUANG J Y, CHEN L, TANG Q,et al.The role of Sirt6 in obesity and diabetes[J]. Front Physiol, 2018, 9: 135.
|
15 |
LI X K, LIU L, LI T, et al. SIRT6 in senescence and aging-related cardiovascular diseases[J]. Front Cell Dev Biol, 2021, 9: 641315.
|
16 |
SILBERMAN D M, ROSS K, SANDE P H, et al. SIRT6 is required for normal retinal function[J]. PLoS One, 2014, 9(6): e98831.
|
17 |
ZORRILLA-ZUBILETE M A, YESTE A, QUINTANA F J, et al. Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6[J]. J Neurochem, 2018, 144(2): 128-138.
|
18 |
WANG D P, DU Y L, XU H Y, et al. Paeonol protects mitochondrial injury and prevents pulmonary vascular remodeling in hypoxia[J]. Respir Physiol Neurobiol, 2019, 268: 103252.
|
19 |
ADKI K M, KULKARNI Y A.Chemistry, pharmacokinetics,pharmacology and recent novel drug delivery systems of paeonol[J]. Life Sci, 2020, 250: 117544.
|
20 |
XU F T, XIAO H M, LIU R B, et al. Paeonol ameliorates glucose and lipid metabolism in experimental diabetes by activating Akt[J]. Front Pharmacol,2019,10:261.
|
21 |
CHEN Y, LIU Z Y, ZHOU F X, et al. Evaluating pharmacological effects of two major components of Shuangdan oral liquid: role of danshensu and paeonol in diabetic nephropathy rat[J]. Biomol Ther (Seoul), 2016, 24(5): 536-542.
|
22 |
LIU D H, AGBO E, ZHANG S H,et al. Anticonvulsant and neuroprotective effects of paeonol in epileptic rats[J]. Neurochem Res, 2019, 44(11): 2556-2565.
|
23 |
SNEZHKINA A V, KUDRYAVTSEVA A V, KARDYMON O L, et al. ROS generation and antioxidant defense systems in normal and malignant cells[J]. Oxid Med Cell Longev, 2019, 2019: 6175804.
|
24 |
BONETTA R. Potential therapeutic applications of MnSODs and SOD-mimetics[J].Chemistry,2018,24(20): 5032-5041.
|
25 |
ZHU Y L, YU X F, GE Q, et al. Antioxidant and anti-aging activities of polysaccharides from Cordyceps cicadae[J]. Int J Biol Macromol, 2020, 157: 394-400.
|
26 |
杨 倩, 刘 媛, 李威威. 虾青素对2型糖尿病大鼠视网膜病变的干预作用及机制研究[J]. 中南医学科学杂志, 2020, 48(5): 505-508.
|
27 |
SUN Y, LIU L, SHI X Y, et al. Paeonol inhibits macrophage M1 polarization by down-regulating miR-155/JAK1-STAT1 pathway[J]. Zhongguo Zhong Yao Za Zhi, 2020, 45(9): 2158-2164.
|
|
*河南中医药大学龙子湖校区2017级中医专业 △河南中医药大学东明校区2020级中医专业
|